# OnCo record nct01127451 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct01127451/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct01127451", "NCT01127451" ;
  schema:name "Study of Denileukin Diftitox in Participants With Stage IIIC and Stage IV Melanoma"@en ;
  schema:description "A phase 2 trial of Denileukin diftitox in Melanoma and Advanced melanoma, run by Eisai Inc., completed."@en ;
  schema:url <https://onco.cc/trials/nct01127451/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01127451> ;
  onco:status "completed" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/advanced-melanoma/> ;
  onco:drugs <https://onco.cc/drugs/denileukin-diftitox/> ;
  onco:companies <https://onco.cc/companies/eisai/> .